跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,718 条关于
“Merz Pharma”
全部
9,718
临床试验
4,142
药物
1,148
机构
1,234
资讯
3,194
去年
TBI Therapeutics Advance Through Clinical Trials: SanBio's SB623 Receives Sakigake Designation
去年
Global Cerebral Palsy Clinical Trial Landscape Assessed in New 2024 Review
上个月
Global Botulinum Toxin Market Poised to Reach $29 Billion by 2035, Driven by Aesthetic Democratization and Expanding Therapeutic Indications
4个月前
Vensica Medical Receives FDA IND Clearance for Phase 2 Trial of Needle-Free Botulinum Toxin Delivery System for Overactive Bladder
去年
XEOMIN Receives First-Ever Approval in Japan for Chronic Sialorrhea Treatment
3个月前
Teijin and Merz Secure Japanese Approval for XEOMIN® in Cervical Dystonia and Blepharospasm
6个月前
German Court Grants Sales Ban for Generic Fampridine Products Following Patent Victory for Merz
前天
Merz Therapeutics Wins EU/EEA Approval for Xeomin in Pediatric Pes Equinus Spasticity
7个月前
Merz Therapeutics Seeks European Approval for XEOMIN in Pediatric Spasticity Treatment
3个月前
Merz Therapeutics Partners with Kvvit to Bring INBRIJA Parkinson's Treatment to Greater China
第 1 页,共 320 页
上一页
下一页